About
Technology
Issues
FAQ
Links
Official Page
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.